Peer-reviewed publication shows that Lateral pharma's SCP drugs for neuropathic pain act via the novel target LanCL1 ...Middle East

MELBOURNE, Australia, June 11, 2026 /PRNewswire/ -- Lateral Pharma today announced the publication of peer-reviewed research in PAIN, a leading journal dedicated to pain research, identifying Lanthionine Synthetase C-Like Protein 1 (LanCL1) as a novel therapeutic target for neuropathic...

Hence then, the article about peer reviewed publication shows that lateral pharma s scp drugs for neuropathic pain act via the novel target lancl1 was published today ( Thursday 11/06/2026 - 11:25 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Peer-reviewed publication shows that Lateral pharma's SCP drugs for neuropathic pain act via the novel target LanCL1 )

Also on site :

• Fans Choose Shakira & Burna Boy’s ‘Dai Dai’ as Best World Cup Song of All Time: Full Results
• List of all FIFA World Cup 2026 matches today & kick-off times (11 June)
• Windows of South Loop high rise shattered during severe storm